Approval · Notice of Compliance 228 · 2002
MUCOMYST: Notice of Compliance 228
Issued February 4, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 228
- Date
- February 4, 2002
- Company
- WellSpring Pharmaceutical Canada Corp.Halifax, Nova Scotia, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Mucolytic, antidote for acetaminophen poisoning
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MUCOMYST | 02091526 | Cancelled Post Market |
Medicinal ingredients
- ACETYLCYSTEINE 200 MG per ML